Structure-Based Kinase Profiling To Understand the Polypharmacological Behavior of Therapeutic Molecules. (Q47290719)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29243930%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

title

Structure-Based Kinase Profiling To Understand the Polypharmacological Behavior of Therapeutic Molecules (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29243930%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29243930%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

author name string

Devawati Dutta

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29243930%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Ranjita Das

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29243930%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Chhabinath Mandal

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29243930%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

publication date

15 December 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29243930%20AND%20SRC:MED&resulttype=core&format=json

Journal of Chemical Information and Modeling

7 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29243930%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29243930%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29243930%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

page(s)

68-89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29243930%20AND%20SRC:MED&resulttype=core&format=json

Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets

7 April 2020

cites work

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage.

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Akt activation enhances ribosomal RNA synthesis through casein kinase II and TIF-IA

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

How does consensus scoring work for virtual library screening? An idealized computer experiment

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian alpha-carbonic anhydrase isoforms.

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Axitinib blocks Wnt/β-catenin signaling and directs asymmetric cell division in cancer

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

mTORC2 regulates hedgehog pathway activity by promoting stability to Gli2 protein and its nuclear translocation

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT/mTOR/P70S6K signaling pathways

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Mahanine, a DNA minor groove binding agent exerts cellular cytotoxicity with involvement of C-7-OH and -NH functional groups.

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

mTOR kinase structure, mechanism and regulation

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

A computational approach to finding novel targets for existing drugs

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Development and validation of a genetic algorithm for flexible docking

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Cell-based proteome profiling of potential dasatinib targets by use of affinity-based probes.

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Cytoscape: a software environment for integrated models of biomolecular interaction networks

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Conformational analysis of the DFG-out kinase motif and biochemical profiling of structurally validated type II inhibitors.

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

The topology of drug-target interaction networks: implicit dependence on drug properties and target families

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

A carbazole alkaloid deactivates mTOR through the suppression of rictor and that induces apoptosis in lung cancer cells

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

PTEN negatively regulates mTORC2 formation and signaling in grade IV glioma via Rictor hyperphosphorylation at Thr1135 and direct the mode of action of an mTORC1/2 inhibitor

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Protein-ligand-based pharmacophores: generation and utility assessment in computational ligand profiling

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Kinase selectivity potential for inhibitors targeting the ATP binding site: a network analysis

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Facing the challenges of structure-based target prediction by inverse virtual screening

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Regorafenib: a guide to its use in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib and sunitinib

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Phosphatase-coupled universal kinase assay and kinetics for first-order-rate coupling reaction

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Regorafenib with a fluoropyrimidine for metastatic colorectal cancer after progression on multiple 5-FU-containing combination therapies and regorafenib monotherapy.

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

High-throughput docking for lead generation

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Computational methods in drug discovery

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Mahanine synergistically enhances cytotoxicity of 5-fluorouracil through ROS-mediated activation of PTEN and p53/p73 in colon carcinoma

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

DrugBank: a comprehensive resource for in silico drug discovery and exploration

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Computational approaches in target identification and drug discovery

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Consensus scoring for ligand/protein interactions

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

BAY 43-9006/Sorafenib blocks CSF1R activity and induces apoptosis in various classical Hodgkin lymphoma cell lines

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Leishmania donovani Aurora kinase: A promising therapeutic target against visceral leishmaniasis

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Comparison of consensus scoring strategies for evaluating computational models of protein-ligand complexes

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases.

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

The structure of Dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer.

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Polypharmacology: challenges and opportunities in drug discovery

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Oxidative inhibition of Hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinoma in vitro and in vivo.

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Predicting polypharmacology by binding site similarity: from kinases to the protein universe

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Distinct binding mode of multikinase inhibitor lenvatinib revealed by biochemical characterization

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

The Protein Data Bank

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

The ChEMBL database in 2017

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2.

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

An enriched structural kinase database to enable kinome-wide structure-based analyses and drug discovery

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

mRAISE: an alternative algorithmic approach to ligand-based virtual screening

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Recovering the true targets of specific ligands by virtual screening of the protein data bank

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Polypharmacology: drug discovery for the future

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Large-scale reverse docking profiles and their applications.

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Ranking targets in structure-based virtual screening of three-dimensional protein libraries: methods and problems

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Cardiotoxicity induced by tyrosine kinase inhibitors

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Recent advances in the treatment of gastrointestinal stromal tumors

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins.

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Targeting the cancer kinome through polypharmacology

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

KinMap: a web-based tool for interactive navigation through human kinome data

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Target deconvolution of bioactive small molecules: the heart of chemical biology and drug discovery

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Benchmark data sets for structure-based computational target prediction

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Exploring polypharmacology using a ROCS-based target fishing approach

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Profile of bosutinib and its clinical potential in the treatment of chronic myeloid leukemia

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Identifying off-target effects and hidden phenotypes of drugs in human cells

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Structure-based predictions of activity cliffs

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

TarFisDock: a web server for identifying drug targets with docking approach

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

A fast flexible docking method using an incremental construction algorithm.

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Signal transduction by vascular endothelial growth factor receptors

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

ReverseScreen3D: a structure-based ligand matching method to identify protein targets

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Identification of direct protein targets of small molecules

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Comprehensive analysis of kinase inhibitor selectivity

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

From in silico target prediction to multi-target drug design: current databases, methods and applications

1 reference

1 January 2022

https://opencitations.net/index/coci/api/v1/references/10.1021/ACS.JCIM.7B00227

Identifiers

DOI

10.1021/ACS.JCIM.7B00227

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29243930%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

1 reference